Kriechbaum, Steffen D.
Rudolph, Felix
Wiedenroth, Christoph B.
Mielzarek, Lisa
Haas, Moritz
Guth, Stefan
Hamm, Christian W.
Mayer, Eckhard
Liebetrau, Christoph
Keller, Till http://orcid.org/0000-0002-0895-6491
Funding for this research was provided by:
Deutsches Zentrum für Herz-Kreislaufforschung
Collaborative Research Center (CRC1213)
Article History
Received: 13 May 2020
Accepted: 27 July 2020
First Online: 3 August 2020
Ethics approval and consent to participate
: The study was approved by the local ethics committee of the Facility of Medicine of the Justus-Liebig-University in Giessen, Germany in July of 2014 (referral numbers 43/14 and 44/14). All participating patients were comprehensively informed by a physician and gave written informed consent.
: All participants gave written informed consent to be included in the study. This manuscript does not include any individual person’s data in any form, including individual details, images or videos. Therefore, no dedicated consent for publication is needed.
: CBW received consultant honoraria and/or speaker fees from Actelion, Bayer AG, MSD, Pfizer and BTG; CWH received lecture or consulting honoraria from BRAHMS/ Thermo Fisher; EM received lecture or consulting honoraria from Actelion, Bayer, MSD, GSK, Pfizer and MSD; CL received lecture or consulting honoraria from Abbott, Astra Zeneca, Bayer, Berlin Chemie, Boehringer Ingelheim, Daiichi-Sankyo and Pfizer-Bristol-Myers Squibb. TK received speaker fees from Abbott and Brahms; SDK, FR and LM have nothing to declare.